Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients

Manoj Mannil, Alessandra Solari, Andreas Leha, Ana L. Pelayo-Negro, José Berciano, Beate Schlotter-Weigel, Maggie C. Walter, Bernd Rautenstrauss, Tuuli J. Schnizer, Angelo Schenone, Pavel Seeman, Chandini Kadian, Olivia Schreiber, Natalia G. Angarita, Gian Maria Fabrizi, Franco Gemignani, Luca Padua, Lucio Santoro, Aldo Quattrone, Giuseppe VitaDaniela Calabrese, C. Marchesi, E. Salsano, L. Nanetti, C. Marelli, V. Scaioli, C. Ciano, M. Rimoldi, G. Lauria, E. Rizzetto, F. Camozzi, E. Narciso, M. Grandis, M. Monti-Bragadin, L. Nobbio, T. Cavallaro, A. Casano, L. Bertolasi, I. Cabrini, K. Corrà, F. Manganelli, C. Pisciotta, M. Nolano, A. Mazzeo, M. Aguennouz, R. Di Leo, G. Majorana, N. Lanzano, F. Valenti, P. Valentino, R. Nisticò, D. Pirritano, A. Lucisano, M. Canino, C. Pazzaglia, G. Granata, M. Foschini, F. Brindani, F. Vitetta, I. Allegri, F. Visioli, P. Bogani, F. Visioli, J. Blake, M. Koltzenburg, E. Hutton, M. Lunn, Peter Young, Matilde Laurà, Jana Haberlová, Radim Mazanec, Walter Paulus, Tim Beissbarth, Michael E. Shy, Mary M. Reilly, Davide Pareyson, Michael W. Sereda

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients'. Together they form a unique fingerprint.

Medicine & Life Sciences